Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins.
Whole-body imaging with fluorescent proteins has been shown to be a powerful technology to follow the dynamics of metastatic cancer. Whole-body imaging of fluorescent protein-expressing-cancer cells enables the facile determination of efficacy of candidate anti-tumor and anti-metastatic agents in mouse models. GFP-expressing transgenic mice transplanted with the RFP-expressing cancer cells enable the distinction of cancer and host cells and the efficacy of drugs on each type of cell. This is particularly useful for imaging tumor angiogenesis. Cancer-cell trafficking through the cardiovascular and lymphatic systems is the critical means of spread of cancer. The use of fluorescent proteins to differentially label cancer calls in the nucleus and cytoplasm and high-powered imaging technology are used to visualize the nuclear-cytoplasmic dynamics of cancer-cell trafficking in both blood vessels and lymphatic vessels in the live animal. This technology has furthered our understanding of the spread of cancer at the subcellular level in the live mouse. Fluorescent proteins thus enable both macro and micro imaging technology and thereby provide the basis for the new field of in vivo cell biology.
Hoffman
Robert M
RM
AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111-3604, USA. all@anticancer.com
D000818:Animals; D003952:Diagnostic Imaging; D004195:Disease Models, Animal; D006801:Humans; D008164:Luminescent Proteins / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*
D008164:Luminescent Proteins
J Surg Res. 2003 Jul;113(1):151-60
12943825
Sensors (Basel). 2008 Feb 22;8(2):1157-1173
27879758
J Virol. 1996 Jul;70(7):4646-54
8676491
J Cell Sci. 1999 Jun;112 ( Pt 12):1835-42
10341203
Cancer Res. 2003 Nov 15;63(22):7785-90
14633704
J Exp Med. 1999 Feb 1;189(3):451-60
9927507
Biotechnology (N Y). 1995 Feb;13(2):151-4
9634755
Cell. 2002 May 3;109(3):335-46
12015983
Cancer Res. 2005 Mar 15;65(6):2337-43
15781648
Cancer Res. 2004 Mar 1;64(5):1828-33
14996746
Gene. 1992 Feb 15;111(2):229-33
1347277
Science. 2002 Jun 7;296(5574):1883-6
11976409
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1206-11
10655509
Nature. 2007 Nov 1;450(7166):56-62
17972876
Nat Med. 2001 Jul;7(7):864-8
11433354
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13291-5
15331785
Cell. 2008 Feb 8;132(3):487-98
18267078
Cancer Res. 2003 Sep 1;63(17):5521-5
14500389
Biotechniques. 2005 Aug;39(2):170, 172
16116787
Cancer Res. 1998 Jun 15;58(12):2528-32
9635573
Nat Biotechnol. 1996 Mar;14(3):315-9
9630892
Nat Biotechnol. 1996 Oct;14(10):1246-51
9631087
Cancer Res. 2000 May 1;60(9):2504-11
10811132
Dev Cell. 2008 Apr;14(4):570-81
18410732
Cancer Res. 2004 Dec 1;64(23):8651-6
15574773
Cancer Res. 2003 Jul 15;63(14):4239-43
12874032
Cancer Res. 2006 Aug 15;66(16):8065-75
16912183
Nature. 1995 Feb 23;373(6516):663-4
7854443
Cancer Res. 2007 Mar 15;67(6):2649-56
17363585
Science. 1990 Apr 6;248(4951):73-6
2321027
Cancer Res. 2005 May 15;65(10):4246-52
15899816
Gene. 1996;173(1 Spec No):33-8
8707053
Cancer Cell. 2002 Apr;1(3):289-98
12086865
Nature. 2007 Oct 4;449(7162):557-63
17914389
Clin Exp Metastasis. 2002;19(4):359-68
12090477
Cancer Res. 2007 Jun 1;67(11):5195-200
17545599
Cancer Res. 1997 May 15;57(10):2042-7
9158003
FEBS Lett. 2000 Aug 18;479(3):127-30
10981720
Cancer Res. 2007 Sep 1;67(17):8223-8
17804736
Trends Biotechnol. 2008 Jan;26(1):1-4
18037177
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3808-14
14506175
Genesis. 2004 Dec;40(4):241-6
15593332
Nat Methods. 2007 Sep;4(9):741-6
17721542
Cancer Res. 2005 Mar 15;65(6):2378-86
15781653
J Cell Physiol. 1971 Jun;77(3):313-8
4397528
Cancer Res. 2004 Jun 15;64(12):4251-6
15205338
Science. 1994 Feb 11;263(5148):802-5
8303295
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11990-5
11050230
Nat Biotechnol. 2004 Dec;22(12):1567-72
15558047
Cell Cycle. 2006 Jan;5(2):191-7
16357534
Clin Exp Metastasis. 1999;17(7):601-7
10845559
Biochemistry. 1993 Feb 9;32(5):1212-8
8448132
Am J Pathol. 1997 Sep;151(3):679-88
9284816
Nat Biotechnol. 1996 May;14(5):606-9
9630951
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14259-62
14614130
Nat Rev Cancer. 2002 Aug;2(8):563-72
12154349
FEBS Lett. 1997 May 5;407(3):313-9
9175875
Cell. 1998 Sep 18;94(6):715-25
9753319
Nat Rev Cancer. 2003 Dec;3(12):921-30
14737122
Cancer Res. 2006 Apr 15;66(8):4208-14
16618743
Cancer. 2003 Jul 15;98(2):413-23
12872364
Nat Rev Cancer. 2005 Oct;5(10):796-806
16195751
J Biomed Opt. 2005 Jul-Aug;10(4):41210
16178634
Nat Biotechnol. 1999 Oct;17(10):969-73
10504696